August 8, 2023 - As per the Alliance for Regenerative Medicine, companies developing cell and gene therapies raised over USD 23.1 billion investments globally in 2021, an increase of about 16% over 2020’s total of USD 19.9 billion.

2 weeks ago - The global biotechnology market is projected to grow from USD 1.77 trillion in 2025 to USD 6.34 trillion by 2035, registering a CAGR of 13.61%. Growth is driven by rising demand for personalized medicine, increasing biopharmaceutical and ...

3 weeks ago - The global biotechnology market size was valued at USD 1,376.1 billion in 2025. The market is projected to grow from USD 1,491.5 billion in 2026 to USD 4,334.8 billion by 2034, exhibiting a CAGR of 14.3% during the forecast period.

July 6, 2026 - Market insights predict the global biotechnology industry will increase to USD 5666.02 billion by 2035 rapidly fueled by breakthroughs in healthcare, agriculture, and industry. With a 12.5% CAGR over the next decade, innovations in gene therapy, CRISPR, AI-driven drug discovery, and mRNA tech ...

May 13, 2026 - The global biotechnology market size was estimated at USD 1,553,853.9 million in 2023 and is projected to reach USD 3,879,508.3 million by 2030, growing at a CAGR of 14.1% from 2024 to 2030.

The global biotechnology market size reached USD 809.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1,391.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.02% during 2026-2034.

September 18, 2025 - The global biotechnology market is projected to grow from USD 1.77 trillion in 2025 to nearly USD 5.71 trillion by 2034, expanding at a robust CAGR of 13.90%. Growth is fueled by the rising demand for biologics, precision medicine, and advanced ...

Biotechnology Market is estimated to be valued at USD 1,163.96 Bn in 2026 and is expected to reach USD 2,654.64 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.

November 20, 2025 - The global biotechnology market size is expected to grow at a CAGR of 18.44% from 2025 to 2033 and was worth USD 1267.28 billion in 2025.

The global biotechnology market size is expected to reach USD 3.88 trillion by 2030, registering a CAGR of 13.96% over the forecast period, according to a new report by Grand View Research, Inc

The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Global Biotechnology industry. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.

December 26, 2025 - The global biotechnology market size was estimated at USD 2.45 trillion in 2025 and is projected to hit around USD 9.06 trillion by 2035, growing at a CAGR of 13.97% during the forecast period from 2026 to 2035.

June 10, 2026 - Global Biotechnology Market size was valued at USD 2171.48 billion in 2024 and is poised to grow from USD 2496.33 billion in 2025 to USD 7615.12 billion by 2033, growing at a CAGR of 14.96% during the forecast period (2026-2033).

March 17, 2026 - Based on Technology, DNA sequencing segment dominated the biotechnology market in 2025 and is expected to hold the largest of nearly 36.17% global market share over the forecast period.

1 month ago - The global biotechnology market size is estimated at USD 1,650 billion in 2025 and is projected to reach USD 5,220 billion by 2034, growing at a CAGR of 13.67% during the forecast period.

July 15, 2025 - The global biotechnology market size is projected to surpass USD 5.71 trillion by 2034, driven by breakthroughs in biologics, tissue engineering, regenerative therapies, and chromatography.

April 9, 2026 - Outsourcing to CMOs and CROs also ... Reuse requires attribution under CC BY 4.0. ... Biopharmaceuticals remained the anchor, holding 45.35% of global revenue in 2025....

Global Biotechnology Market Size is Expected to Grow USD 9153.8 Billion by 2035, at a CAGR of 14.06% and segments are By Technology, By Application

March 24, 2026 - The growing demand for biopharmaceuticals is a major driver of biotechnology market growth, as biologic drugs like monoclonal antibodies, vaccines, and cell therapies offer targeted treatments with fewer side effects compared to traditional medications. Biopharmaceuticals are particularly effective in treating complex chronic diseases, including cancer, autoimmune disorders, and genetic conditions. Their efficacy and specificity are fueling global demand, prompting biopharma companies to expand R&D investments.